These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20552297)

  • 1. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
    Wu BX; Clarke CJ; Hannun YA
    Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral Sphingomyelinases in Cancer: Friend or Foe?
    Clarke CJ
    Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral sphingomyelinases and nSMase2: bridging the gaps.
    Clarke CJ; Hannun YA
    Biochim Biophys Acta; 2006 Dec; 1758(12):1893-901. PubMed ID: 16938269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.
    Ito H; Murakami M; Furuhata A; Gao S; Yoshida K; Sobue S; Hagiwara K; Takagi A; Kojima T; Suzuki M; Banno Y; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Nozawa Y; Murate T
    Biochim Biophys Acta; 2009; 1789(11-12):681-90. PubMed ID: 19698806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
    Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
    Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.
    Shamseddine AA; Airola MV; Hannun YA
    Adv Biol Regul; 2015 Jan; 57():24-41. PubMed ID: 25465297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
    Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
    Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.
    Yabu T; Imamura S; Yamashita M; Okazaki T
    J Biol Chem; 2008 Oct; 283(44):29971-82. PubMed ID: 18678863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure.
    Zager RA; Conrad S; Lochhead K; Sweeney EA; Igarashi Y; Burkhart KM
    Kidney Int; 1998 Mar; 53(3):573-82. PubMed ID: 9507201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
    Taniguchi M; Okazaki T
    Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
    Marchesini N; Luberto C; Hannun YA
    J Biol Chem; 2003 Apr; 278(16):13775-83. PubMed ID: 12566438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes.
    Magnoni C; Euclidi E; Benassi L; Bertazzoni G; Cossarizza A; Seidenari S; Giannetti A
    Toxicol In Vitro; 2002 Aug; 16(4):349-55. PubMed ID: 12110272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide.
    Lin M; Liao W; Dong M; Zhu R; Xiao J; Sun T; Chen Z; Wu B; Jin J
    FEBS J; 2018 Oct; 285(20):3835-3848. PubMed ID: 30106227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling sphingomyelinases: which, where, how and why?
    Levade T; Jaffrézou JP
    Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation.
    Zeidan YH; Hannun YA
    Curr Mol Med; 2010 Jul; 10(5):454-66. PubMed ID: 20540705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelinases and Liver Diseases.
    Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi.
    Gu L; Huang B; Shen W; Gao L; Ding Z; Wu H; Guo J
    J Neuroinflammation; 2013 Sep; 10():109. PubMed ID: 24007266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide signalling and the immune response.
    Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
    Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.
    Matmati N; Hannun YA
    J Lipid Res; 2008 May; 49(5):922-8. PubMed ID: 18305313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling.
    Yabu T; Shiba H; Shibasaki Y; Nakanishi T; Imamura S; Touhata K; Yamashita M
    Cell Death Differ; 2015 Feb; 22(2):258-73. PubMed ID: 25168245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.